combination of ccr5 and cxcr4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.

NLM AIDSLINE Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections. Rusconi S; La Seta Catamancio S; Citterio P; Bulgheroni E; Croce F;
December 30, 2000

J Virol. 2000 Oct;74(19):9328-32. Unique Identifier : AIDSLINE We studied the combined anti-human immunodeficiency virus type 1 (HIV-1) effects of a derivative of stroma-derived factor 1beta (SDF-1beta), Met-SDF-1beta, and a modified form of RANTES, aminooxypentane (AOP)-RANTES. The antiviral agents were tested singly or in combination at 95 and 99% virus inhibitory concentrations. Clinical R5 and X4 HIV-1 isolates were used. AOP-RANTES inhibited R5 but not X4 viruses, whereas Met-SDF-1beta had the opposite effect. Combinations of these compounds inhibited mixed infections with R5 and X4 viruses (95 to 99%), whereas single drugs were less inhibitory (32 to 61%). Combinations of R5 and X4 inhibitors are promising and deserve further evaluation. JOURNAL ARTICLE Amino Acid Sequence Anti-HIV Agents/PHARMACOLOGY/THERAPEUTIC USE Cell Line Cytokines/CHEMISTRY/PHARMACOLOGY/THERAPEUTIC USE Genome, Viral Human HIV Infections/DRUG THERAPY/VIROLOGY HIV-1/GENETICS Molecular Sequence Data Receptors, CCR5/ANTAGONISTS & INHIB Receptors, CXCR4/ANTAGONISTS & INHIB RANTES/ANALOGS & DERIVATIVES/*PHARMACOLOGY/THERAPEUTIC USE Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused DELAWARE: Cape Henlopen Theatre Academy to Host 'Magic to Do' May 25 GLOBAL: HIV Outcomes Could Improve by Integrating Treatment of Comorbid Mental Illness CANADA: Stop Paid Blood Donor Clinics in Toronto, Victims Say UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations HHS Office for Civil Rights launches campaign to increase awareness of HIPAA rights among HIV-positive Black men Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog Study Finds Vitamin C Can Kill Drug-Resistant TB When it comes to deadly viruses, what's in a name?UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Navajo Confront an Increase in New H.I.V. Infections UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Researchers from Albert Einstein College of Medicine Report Details of New Studies and Findings in the Area of HIV/AIDS THE NETHERLANDS: High Prevalence of Oral HPV Infection in Dutch Gay Men
Information in this article was accurate in December 30, 2000. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.